ArticlebioRxiv : the preprint server for biology2026
Proteomic profiling across early postnatal development of midbrain dopamine axons innervating the dorsal striatum.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Precise wiring and tuning of dopamine axons in the brain is crucial for normal development of basal ganglia circuits. This process takes place both pre and postnatally, with early postnatal windows reflecting important periods of terminal maturation. Protein expression and precise localization are vital to this process, underlying changes in axon structure and function. Yet, technical hurdles have prohibited mapping protein expression and localization as dopamine axons mature to form functional release sites. Here we employ targeted proximity labeling in midbrain dopamine neurons and track isolated distal axonal proteins in the striatum across development, from the neonatal period through adolescence. Our approach enabled high-precision evaluation of the axonal proteome, supported by a combination of Cre-recombinase based restriction and spatial separation. We map co-varying subpopulations of axonal proteins differentially expressed across development. Microtubule-associated proteins decreased over time, revealing temporal dynamics of dopaminergic axon stabilization at the proteomic level. Conversely, proteins supporting coordinated action potential firing increased over time, likely contributing to the characteristic tonic firing of dopamine neurons emerging over development. Intersecting our findings with recent GWAS of psychiatric and neurological disorders provided functional confirmation of disease and disorder risk. This analysis highlighted early expression and localization of risk gene products, providing spatial-temporal points of convergence for disease-associated variants specifically to the initial stages of postnatal neurodevelopment of dopamine neurons. Together, these findings provide the essential grounding for understanding postnatal dopaminergic axon development and contextualize neurodevelopmental functions for numerous risk gene products.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.